chr9-69012840-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002732.4(PRKACG):c.*197C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0795 in 572,552 control chromosomes in the GnomAD database, including 2,707 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.083 ( 619 hom., cov: 30)
Exomes 𝑓: 0.078 ( 2088 hom. )
Consequence
PRKACG
NM_002732.4 3_prime_UTR
NM_002732.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0300
Genes affected
PRKACG (HGNC:9382): (protein kinase cAMP-activated catalytic subunit gamma) Cyclic AMP-dependent protein kinase (PKA) consists of two catalytic subunits and a regulatory subunit dimer. This gene encodes the gamma form of its catalytic subunit. The gene is intronless and is thought to be a retrotransposon derived from the gene for the alpha form of the PKA catalytic subunit. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-69012840-G-C is Benign according to our data. Variant chr9-69012840-G-C is described in ClinVar as [Benign]. Clinvar id is 1251250.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.228 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKACG | NM_002732.4 | c.*197C>G | 3_prime_UTR_variant | 1/1 | ENST00000377276.5 | NP_002723.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKACG | ENST00000377276.5 | c.*197C>G | 3_prime_UTR_variant | 1/1 | NM_002732.4 | ENSP00000366488 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0832 AC: 12096AN: 145382Hom.: 620 Cov.: 30
GnomAD3 genomes
AF:
AC:
12096
AN:
145382
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0782 AC: 33402AN: 427062Hom.: 2088 Cov.: 4 AF XY: 0.0776 AC XY: 17382AN XY: 224038
GnomAD4 exome
AF:
AC:
33402
AN:
427062
Hom.:
Cov.:
4
AF XY:
AC XY:
17382
AN XY:
224038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0832 AC: 12105AN: 145490Hom.: 619 Cov.: 30 AF XY: 0.0840 AC XY: 5966AN XY: 71010
GnomAD4 genome
AF:
AC:
12105
AN:
145490
Hom.:
Cov.:
30
AF XY:
AC XY:
5966
AN XY:
71010
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 21, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at